IN2015DN01018A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN01018A IN2015DN01018A IN1018DEN2015A IN2015DN01018A IN 2015DN01018 A IN2015DN01018 A IN 2015DN01018A IN 1018DEN2015 A IN1018DEN2015 A IN 1018DEN2015A IN 2015DN01018 A IN2015DN01018 A IN 2015DN01018A
- Authority
- IN
- India
- Prior art keywords
- acetoxy
- propoxy
- diphenyl
- alkyl
- methyl
- Prior art date
Links
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 abstract 2
- -1 piperidinium halides Chemical class 0.000 abstract 2
- 229940121683 Acetylcholine receptor antagonist Drugs 0.000 abstract 1
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 abstract 1
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261681415P | 2012-08-09 | 2012-08-09 | |
| PCT/US2013/052626 WO2014025569A1 (fr) | 2012-08-09 | 2013-07-30 | Sels de pipéridinium quartenaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN01018A true IN2015DN01018A (fr) | 2015-06-26 |
Family
ID=50068488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1018DEN2015 IN2015DN01018A (fr) | 2012-08-09 | 2013-07-30 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9896416B2 (fr) |
| EP (1) | EP2882711B1 (fr) |
| JP (1) | JP6345665B2 (fr) |
| KR (2) | KR20150040355A (fr) |
| CN (2) | CN108658842A (fr) |
| AU (1) | AU2013300009B2 (fr) |
| BR (1) | BR112015002832B1 (fr) |
| CA (1) | CA2881182C (fr) |
| EA (1) | EA029678B9 (fr) |
| HK (1) | HK1211572A1 (fr) |
| IL (1) | IL236996A0 (fr) |
| IN (1) | IN2015DN01018A (fr) |
| MX (1) | MX356386B (fr) |
| WO (1) | WO2014025569A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3265128A4 (fr) | 2015-03-06 | 2018-09-12 | Chase Pharmaceuticals Corporation | Combinaison d'agoniste des récepteurs muscariniques et d'oxybutynine dans un système thérapeutique transdermique |
| US20180360845A1 (en) * | 2015-07-20 | 2018-12-20 | Chase Pharmaceuticals Corporation | Muscarinic combination of a selective m2-antagonist and a peripheral non-selective antagonist for treating hypocholinergic disorders |
| EP3864810B1 (fr) | 2019-08-22 | 2023-12-20 | Ofinno, LLC | Contrôle de politique pour accès multiples |
| CN117018194A (zh) * | 2023-07-26 | 2023-11-10 | 同济大学 | 毒蕈碱型受体5型受体拮抗剂的用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD106643A1 (fr) * | 1973-07-12 | 1974-06-20 | ||
| CN1285348A (zh) | 1999-08-20 | 2001-02-28 | 广东康美药业股份有限公司 | 盐酸丙哌维林合成工艺 |
| DE10129832A1 (de) | 2001-06-17 | 2003-07-10 | Berolina Drug Dev Ab Svedala | Deuterierte N- und alpha-substituierte Diphenylalkoxyessigsäureaminoalkylester sowie diese Verbindungen enthaltende Arzneimittel |
| CA2384922C (fr) * | 2002-05-03 | 2008-09-02 | Purepharm Inc. | Produit topique de glycopyrrolate pour reduire la transpiration |
| KR100500760B1 (ko) | 2003-07-22 | 2005-07-14 | 동방에프티엘 주식회사 | 염산 프로피베린의 제조방법 |
| KR100510788B1 (ko) | 2003-07-22 | 2005-08-26 | 동방에프티엘 주식회사 | 프로필벤질릭산 에스터로부터 염산 프로피베린의 제조방법 |
| JP4819699B2 (ja) * | 2004-02-06 | 2011-11-24 | メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト | 喘息及びｃｏｐｄの長期間の治療のための抗コリン作用薬及びグルココルチコイドの組合せ剤 |
| CA2618933C (fr) * | 2005-08-12 | 2016-09-20 | Dietmar Plenz | Mesure de l'avalanche neuronale |
| CN1951938A (zh) * | 2005-10-21 | 2007-04-25 | 刘丽娅 | 戊乙奎醚季铵盐及其衍生物 |
| SE0600876L (sv) | 2006-04-20 | 2007-10-21 | Sandvik Intellectual Property | Verktyg och skär för spånavskiljande bearbetning med primära och sekundära ingreppsmedel med rotationssymmetrisk form |
| CN101490003A (zh) * | 2006-04-24 | 2009-07-22 | 阿斯利康(瑞典)有限公司 | 具有毒蕈碱m3受体拮抗剂活性、用于治疗入慢性支气管阻塞、哮喘和膀胱过动的新型环状氨基醇的取代烷基酯类化合物 |
| JP2009534463A (ja) * | 2006-04-24 | 2009-09-24 | アストラゼネカ・アクチエボラーグ | 例えば慢性気管支閉塞、喘息および過活動膀胱の処置に有用な、ムスカリンｍ３受容体アンタゴニスト活性を有する環状アミノアルコールの新規アルキルエステル |
| KR20120023059A (ko) * | 2010-03-15 | 2012-03-12 | 라마크리시나 라메샤 안다가 | 프로피베린 염산염의 합성 |
| KR101149821B1 (ko) | 2010-04-05 | 2012-05-24 | 하나제약 주식회사 | 디페닐아세테이트 유도체의 새로운 제조방법 |
| CN102218063B (zh) | 2011-04-12 | 2013-03-13 | 贵州神奇制药有限公司 | 盐酸丙哌维林药物的制备方法和产品及其检测方法 |
| EP2892514A4 (fr) * | 2012-09-05 | 2016-04-13 | Chase Pharmaceuticals Corp | Composition et procédés neuroprotecteurs anticholinergiques |
-
2013
- 2013-07-30 IN IN1018DEN2015 patent/IN2015DN01018A/en unknown
- 2013-07-30 CN CN201810664740.3A patent/CN108658842A/zh active Pending
- 2013-07-30 EP EP13827594.6A patent/EP2882711B1/fr active Active
- 2013-07-30 WO PCT/US2013/052626 patent/WO2014025569A1/fr not_active Ceased
- 2013-07-30 KR KR20157006047A patent/KR20150040355A/ko not_active Ceased
- 2013-07-30 AU AU2013300009A patent/AU2013300009B2/en not_active Ceased
- 2013-07-30 KR KR1020207005139A patent/KR102240999B1/ko not_active Expired - Fee Related
- 2013-07-30 MX MX2015001769A patent/MX356386B/es active IP Right Grant
- 2013-07-30 US US14/419,381 patent/US9896416B2/en active Active
- 2013-07-30 HK HK15112219.3A patent/HK1211572A1/xx unknown
- 2013-07-30 CA CA2881182A patent/CA2881182C/fr active Active
- 2013-07-30 BR BR112015002832-2A patent/BR112015002832B1/pt not_active IP Right Cessation
- 2013-07-30 EA EA201500209A patent/EA029678B9/ru unknown
- 2013-07-30 CN CN201380042085.3A patent/CN104603108A/zh active Pending
- 2013-07-30 JP JP2015526567A patent/JP6345665B2/ja not_active Expired - Fee Related
-
2015
- 2015-01-29 IL IL236996A patent/IL236996A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6345665B2 (ja) | 2018-06-20 |
| US20150203452A1 (en) | 2015-07-23 |
| WO2014025569A1 (fr) | 2014-02-13 |
| KR102240999B1 (ko) | 2021-04-15 |
| EA029678B9 (ru) | 2018-07-31 |
| CA2881182A1 (fr) | 2014-02-13 |
| KR20200022522A (ko) | 2020-03-03 |
| MX2015001769A (es) | 2015-05-08 |
| BR112015002832B1 (pt) | 2022-08-16 |
| CA2881182C (fr) | 2021-01-26 |
| KR20150040355A (ko) | 2015-04-14 |
| IL236996A0 (en) | 2015-03-31 |
| CN104603108A (zh) | 2015-05-06 |
| BR112015002832A2 (fr) | 2017-07-04 |
| AU2013300009A1 (en) | 2015-02-26 |
| EA029678B1 (ru) | 2018-04-30 |
| MX356386B (es) | 2018-05-28 |
| EP2882711A4 (fr) | 2016-02-10 |
| HK1211572A1 (en) | 2016-05-27 |
| JP2015524469A (ja) | 2015-08-24 |
| US9896416B2 (en) | 2018-02-20 |
| AU2013300009B2 (en) | 2017-06-15 |
| EP2882711B1 (fr) | 2017-10-25 |
| EP2882711A1 (fr) | 2015-06-17 |
| CN108658842A (zh) | 2018-10-16 |
| EA201500209A1 (ru) | 2015-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201290984A1 (ru) | Гелеобразные фармацевтические композиции, препятствующие злоупотреблению | |
| IL235767A (en) | Preserved pyrolidines, pharmaceuticals containing them and their uses | |
| MX2014011217A (es) | Moduladores del receptor de estrogeno y sus usos. | |
| EP4249055A3 (fr) | Formes pharmaceutiques orales de tofacitinib à libération prolongée | |
| ZA201405101B (en) | "new indolizine compounds, a process for their preparation and pharmaceutical compositions containing them." | |
| MX2015008069A (es) | Conjunto de envasado para dispositivos de administracion de farmacos. | |
| IT1404931B1 (it) | Composizioni oftalmiche per la somministrazione di principi attivi liposolubili . | |
| IN2015DN03984A (fr) | ||
| IL236057B (en) | History of 4,2,1-triazine-6-carboxamide and pharmaceutical preparations containing them | |
| GEP201706739B (en) | Compositions comprising vortioxetine and donepezil | |
| UY34730A (es) | Formulaciones farmacéuticas que comprenden antagonistas de ccr3 | |
| PH12014502856A1 (en) | Solid pharmaceutical preparation containing levothyroxine | |
| MY183068A (en) | Pharmaceutical formulation comprising antibody | |
| MD20150053A2 (ro) | Produs de comicronizare cu conţinut de acetat de ulipristal | |
| IN2015DN01018A (fr) | ||
| WO2014133744A3 (fr) | Compositions orales de soin | |
| IL246298A0 (en) | History of piperidine, their preparation and pharmaceutical preparations containing them | |
| TN2015000267A1 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
| IL233055A0 (en) | (1r,r4) 7-oxo-2-azabicyclo [2.2.2] oct-5-ene and its derivatives | |
| IN2015DN02999A (fr) | ||
| WO2015022560A8 (fr) | Composition pharmaceutique stable contenant du bisoprolol et du ramipril | |
| WO2014115169A3 (fr) | Dispersion solide de crizotinib | |
| WO2017004172A8 (fr) | Synthèse totale de shishijimicine a et d'analogues de celle-ci | |
| WO2014133746A3 (fr) | Compositions pour soins d'hygiène buccale | |
| WO2014122671A3 (fr) | Compositions orales solides de saxagliptine |